Abstracts Archive - Page 2299 of 2607 - ACR Meeting Abstracts

Abstract Number: 2022 • 2013 ACR/ARHP Annual Meeting
The Comparison Between IgG4-Related Retroperitoneal Fibrosis and Idiopathic Retroperitoneal Fibrosis
Bon San Koo¹, Bin Yoo¹, Chang-Keun Lee¹, Yong-Gil Kim¹, You Jae Kim¹, Seokchan Hong², Wook Jang Seo³ and Kyung joo Ahn⁴, ¹Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ²Department of rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ³Seoul Veterans Hospital, Seoul, South Korea, ⁴KEPCO medical center, Seoul, South Korea
The comparison between IgG4-related retroperitoneal fibrosis and idiopathic retroperitoneal fibrosis Background/Purpose: The purpose of our study was to identify the ratio of IgG4-related retroperitoneal fibrosis…
Abstract Number: 2023 • 2013 ACR/ARHP Annual Meeting
IgG4-Related Midline Destructive Lesion: Expanding The Spectrum Of Organ Involvement In IgG4-Related Disease
Emanuel Della Torre¹, Donald Krause², Vikram Deshpande³, Vinay Mahajan⁴, Hamid Mattoo⁵, Shiv Pillai⁶ and John Stone⁷, ¹Cancer Center, Massachusetts General Hospital, Boston, MA, ²Medicine, St. Joseph's Hospital, Bangor, ME, ³Pathology, Massachusetts General Hospital, Boston, MA, ⁴Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁶Oncology, Massachusetts General Hospital, Boston, MA, ⁷Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Midline destructive lesion (MDL) is a fibroinflammatory condition involving the nose, paranasal sinuses, and palate with relentless erosion through contiguous facial structures. A variety…
Abstract Number: 2024 • 2013 ACR/ARHP Annual Meeting
Elevated IgG4+ Plasmablasts In Patients With Active, Untreated IgG4-Related Disease
Zachary S. Wallace¹, Vinay Mahajan², Mollie Carruthers³, Hamid Mattoo⁴, Shiv Pillai⁵ and John H. Stone³, ¹Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ²Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Rheumatology, Massachusetts General Hospital, Boston, MA, ⁴Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Oncology, Massachusetts General Hospital, Boston, MA
Background/Purpose: IgG4-delated disease (IgG4-RD) is an immune-mediate condition responsible for inflammatory lesions that can affect nearly every organ. Diagnosis is challenging as it relies upon…
Abstract Number: 2025 • 2013 ACR/ARHP Annual Meeting
Distinctive Expression Profiles Of Long Intergenic Non-Coding RNA Between Polymyalgia Rheumatica and Rheumatoid Arthritis Might Contains Helpful Suggestions For Understanding and Discriminating These Diseases
Yoshinobu Koyama¹, Motohiko Tanino², Hirokazu Shiraishi³, Shuji Nagano⁴, Toshiyuki Ota⁴ and Toshie Higuchi⁵, ¹Division of Rheumatology, Okayama Red Cross General Hospital, Okayama, Japan, ²DNA Chip Research Inc., Yokohama, Japan, ³Orthopedics, Iizuka Hospital, Iizuka, Japan, ⁴Center for Rheumatic Diseases, Iizuka Hospital, Iizuka, Japan, ⁵Center for Autoimmune Diseases, Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan
Background/Purpose: There are many clinical similarities between polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA). It has been reported that the specificity for discriminating PMR from…
Abstract Number: 2026 • 2013 ACR/ARHP Annual Meeting
Initial Dose Of Prednisolone For Japanese Patients With Polymyalgia Rheumatica
Akiko Aoki¹, Hiroshi Oka² and Mitsuyuki Nakamura³, ¹General Medicien, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan, ²Rheumatic Disease Center, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan, ³Rheumatology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
Background/Purpose: Polymyalgia rheumatica (PMR) is a common inflammatory condition of elderly persons. Clinical symptoms respond to low-dose glucocorticoids, but treatment is often required for several…
Abstract Number: 2027 • 2013 ACR/ARHP Annual Meeting
Treatment Of Refractory Adult-Onset Still’s Disease With Abatacept : Report Of Five Cases
Hye Jin Oh¹, Myung Jae Yun², Kyong Rok Kim², Sang Hyun Joo², Jae Myung Lee², Jin Kyun Park², Eun Bong Lee², Yeong Wook Song³ and Eun Young Lee², ¹Internal Medicine, Rheumatology, Seoul National University Hospital, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, ³Internal Medicine,Rheumatology, Seoul National University Hospital, Seoul, South Korea
Background/Purpose: Adult onset Still’s disease (AOSD) is a rare disorder of unknown etiology and systemic inflammatory disorder characterized by spiking fever, arthritis, evanescent rash and…
Abstract Number: 2028 • 2013 ACR/ARHP Annual Meeting
Efficacy and Safety Of Biologic Agents In Adult-Onset Still’s Disease: A Long-Term Follow-Up Of 19 Patients At a Single Referral Center
Giulio Cavalli^1,2, Stefano Franchini¹, Alvise Berti¹, Corrado Campochiaro¹, Barbara Guglielmi¹, Maria Grazia Sabbadini¹, Elena Baldissera³ and Lorenzo Dagna^4,5, ¹Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy, ²San Raffaele Scientific Institute, Milan, Italy, ³Vita-Salute San Raffaele University, Milano, Italy, ⁴Vita-Salute San Raffaele University, Milan, Italy, ⁵Medicine and Clinical Immunology, San Raffaele Scientific Institute, Milan, Italy
Background/Purpose: No data comparing the long-term outcome of Adult-Onset Still’s Disease (AOSD) patients treated with different biological drugs is currently available. We evaluated the efficacy…
Abstract Number: 1991 • 2013 ACR/ARHP Annual Meeting
Gout In Ambulatory Care Settings In The US: 1993-2009
Eswar Krishnan and Linjun Chen, Medicine, Stanford University, Palo Alto, CA
Background/Purpose: Gouty arthritis (gout) is primarily cared for in ambulatory care settings. Yet, there are few nationally representative data on ambulatory health care utilization of…
Abstract Number: 1992 • 2013 ACR/ARHP Annual Meeting
Trends In Outpatient Treatment Of Gout In The US: From 1993 To 2009
Eswar Krishnan and Linjun Chen, Medicine, Stanford University, Palo Alto, CA
Background/Purpose: Gouty arthritis (gout) is primarily managed in the community by primary care providers. Relatively little is known about the treatment patterns as well as…
Abstract Number: 2000 • 2013 ACR/ARHP Annual Meeting
Changes In The Prevalence Of Gout In The United States General Population Between 1960 and 2010: The National Health and Nutrition Examination Surveys
Eswar Krishnan and Linjun Chen, Medicine, Stanford University, Palo Alto, CA
Background/Purpose: Despite the widely shared impression that the prevalence of gouty arthritis (gout) has increased over time in the US few population data are available.…
Abstract Number: 1989 • 2013 ACR/ARHP Annual Meeting
Determinants Of Functional Disability In Patients With Gout: Longitudinal Analysis From a Multicentre Observational Study Of The Italian Society For Rheumatology
Carlo Alberto Scirè¹, Maria Manara¹, Greta Carrara¹, Marco A. Cimmino², Marcello Govoni³, Fausto Salaffi⁴, Leonardo Punzi⁵, Carlomaurizio Montecucco⁶, Marco Matucci-Cerinic⁷ and Giovanni Minisola⁸, ¹Epidemiology Unit -Italian Society for Rheumatology, Milano, Italy, ²Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, ³Clinical and Experimental Medicine, Section of Rheumatology, University of Ferrara, Ferrara, Italy, ⁴Rheumatology Unit - Polytechnic University of the Marche, Jesi, Italy, ⁵Department of Medicine - DIMED, University of Padova, Padova, Italy, ⁶Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy, ⁷Rheumatology, University of Florence, Azienda Ospedaliera Careggi, Florence, Italy, ⁸Rheumatology Unit, San Camillo-Forlanini Hospital, Rome, Italy
Background/Purpose: Gout is the most prevalent arthritis and significantly impacts on function. Beside the influence of concurrent comorbidities, identifying disease-related prognostic factors may help to…
Abstract Number: 1990 • 2013 ACR/ARHP Annual Meeting
Treatment Of ACUTE Gout In The Emergency Department Evaluated According To The 2012 American College Of Rheumatology Guidelines
Naomi Schlesinger¹, Tina Chang Young², Diane C. Radvanski³, Dirk Moore⁴ and Robert Eisenstein⁵, ¹Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, ²Department of Biostatistics, UMDNJ/School of Public Health, Piscataway, NJ, ³Department of Medicine, Division of Rheumatology, Robert Wood Johnson Medical School, New Brunswick, NJ, ⁴Department of Biostatistics, UMDNJ - School of Public Health, Piscataway, NJ, ⁵, Department of Emergency Medicine, UMDNJ- Robert Wood Johnson Medical School, New Brunswick, NJ
Background/Purpose: Acute gout attacks account for a substantial number of emergency department (ED) visits. Our aim was to record acute gout treatment in the ED…
Abstract Number: 1993 • 2013 ACR/ARHP Annual Meeting
Geographic Variations Of Gout Epidemiology In The United Kingdom: A Nationwide Population Study
Chang-Fu Kuo^1,2, Michael Doherty³, Matthew J. Grainge⁴ and Weiya Zhang¹, ¹Academic Rheumatology, School of Clinical Sciences, University of Nottingham, Nottingham, United Kingdom, ²Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taipei, Taiwan, ³Academic Rheumatology, University of Nottingham, Nottingham, United Kingdom, ⁴Division of Epidemiology and Public Health, School of Community Health Sciences,, University of Nottingham, Nottingham, United Kingdom
Background/Purpose: To examine geographic variations of gout prevalence, incidence and management in the United Kingdom. Methods: We used the Clinical Practice Research Data-link (CPRD) to…
Abstract Number: 1994 • 2013 ACR/ARHP Annual Meeting
Performance Of Gout Impact Scale Of The Gout Assessment Questionnaire In a Longitudinal Observational Study Of Patients With Gout
Puja Khanna¹, Cleopatra Aquino-Beaton², Jasvinder A. Singh³, Erin Duffy⁴, David Elashoff⁵ and Dinesh Khanna⁶, ¹Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, ²Rheumatology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, ³Department of Medicine, University of Alabama, Tuscaloosa, AL, ⁴Medicine, University of California Los Angeles, Los Angeles, CA, ⁵Medicine- Statistic Core, UCLA Department of Medicine Statistics Core, Los Angeles, CA, ⁶University of Michigan Health System, Ann Arbor, MI
Background/Purpose: Gout Assessment Questionnaire (GAQ2.0) is a validated disease-specific measure used to evaluate patient reported outcomes in gout studies. The objective was to evaluate the…
Abstract Number: 1995 • 2013 ACR/ARHP Annual Meeting
Serum Homocysteine Related To Decreased Renal Function In Chronic Gouty Patients
Jung-Soo Song¹, Jin Su Kim² and Sang Tae Choi¹, ¹Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, ²Chung-Ang University College of Medicine, Seoul, South Korea
Background/Purpose: Homocysteine is a non-essential amino acid formed by the conversion of methionine to cysteine. Hyperhomocysteinemia is a risk factor for cardiovascular events by inducing…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].